Literature DB >> 7589496

The complete Consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solution.

W F Vranken1, M Budesinsky, F Fant, K Boulez, F A Borremans.   

Abstract

The disulfide bridge closed cyclic peptide corresponding to the whole Consensus V3 loop of the envelope protein gp120 of HIV-1 was examined by proton 2D-NMR spectroscopy in water and in a 20% trifluoroethanol/water solution. In water, NOE data support a beta-turn conformation for the central conservative GPGR region and point towards partial formation of a helix in the C-terminal part. Upon addition of trifluoroethanol, a C-terminal helix is formed. This is evidenced by NOE data, alpha-proton chemical shift changes and changes in the JN alpha vicinal coupling constants. The C-terminal helix is amphipathic and also occurs in other examined strains. It could therefore be an important feature for the functioning of the V3 loop.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589496     DOI: 10.1016/0014-5793(95)01086-t

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120.

Authors:  Miklos Guttman; Maria Kahn; Natalie K Garcia; Shiu-Lok Hu; Kelly K Lee
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  Dynamic domains and geometrical properties of HIV-1 gp120 during conformational changes induced by CD4 binding.

Authors:  Shu-Qun Liu; Shi-Xi Liu; Yun-Xin Fu
Journal:  J Mol Model       Date:  2006-11-28       Impact factor: 1.810

3.  CCR5 interactions with the variable 3 loop of gp120.

Authors:  Kelby B Napier; Zi-xuan Wang; Stephen C Peiper; John O Trent
Journal:  J Mol Model       Date:  2006-05-24       Impact factor: 1.810

4.  Molecular motions of human HIV-1 gp120 envelope glycoproteins.

Authors:  Shu-Qun Liu; Shi-Xi Liu; Yun-Xin Fu
Journal:  J Mol Model       Date:  2008-07-02       Impact factor: 1.810

5.  Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.

Authors:  Robyn L Stanfield; Miroslaw K Gorny; Susan Zolla-Pazner; Ian A Wilson
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 6.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

7.  On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.

Authors:  Susanna L Lamers; Gary B Fogel; Enoch S Liu; Marco Salemi; Michael S McGrath
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-01       Impact factor: 2.205

Review 8.  Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

Authors:  M L Bellows; C A Floudas
Journal:  Curr Drug Targets       Date:  2010-03       Impact factor: 3.465

9.  Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage.

Authors:  Majid Masso; Iosif I Vaisman
Journal:  BMC Bioinformatics       Date:  2010-10-05       Impact factor: 3.169

10.  Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.

Authors:  Amit Mor; Eugenia Segal; Brenda Mester; Boris Arshava; Osnat Rosen; Fa-Xiang Ding; Joseph Russo; Amnon Dafni; Fabian Schvartzman; Tali Scherf; Fred Naider; Jacob Anglister
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.